Sulindac sulfide inhibits the proliferation of colon cancer cells: Diminished expression of the proliferation markers PCNA and Ki-67

Cancer Letters

Volumn 115, Issue 2, 1997, Pages 229-234

  Qiao, Liang ^a,c   Shiff, Steven J ^a,b   Rigas, Basil ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Apoptosis; Colon cancer; Cyclooxygenase; NSAIDs; Proliferation; Sulindac

Indexed keywords

CYCLINE; KI 67 ANTIGEN; PROSTAGLANDIN; SULINDAC SULFIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL COUNT; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; HL-60 CELLS; HT29 CELLS; HUMANS; KI-67 ANTIGEN; PROLIFERATING CELL NUCLEAR ANTIGEN; SULINDAC; TUMOR MARKERS, BIOLOGICAL;

EID: 0030938529     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04740-X     Document Type: Article

References (21)

1. Biasco, G., Paganelli, G.M., Santucci, R., Brandi, G. and Barbara, L. (1994) Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk, J. Cell. Biochem., Suppl., 19, 55-60.
2. Gerdes, J., Lemke, H., Baisch, H., Wacker, H.H., Schwab, U. and Stein, H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J. Immunol., 133, 1710-1715.
3. Gerds, J. (1990) Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. In: Seminar in Cancer Biology, pp. 99-206. Editor: M. Osborn. Saunders, London.
4. McCormick, D., Chong, H., Hobbs, C., Datta, C. and Hall, P.A. (1995) Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1, Histopathology, 22, 355-360.
5. Henriksen, R., Strang, P., Backstrom, T., Wilander, E., Tribukait, B. and Oberg, K (1994) Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers. Anticancer Res., 14, 603-608.
6. Miller, T.P., Grogan, T.M., Dalberg, S., Spier, C.M., Braziel, R.M., Banks, P.M., Foucar, K., Kjeldsberg, C.R., Levy, N. and Nathwani, B.N. (1994) Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective southwest oncology group trial, Blood, 83, 1460-1466.
7. Gasparini, G., Boracchi, P., Verderio, P. and Bevilacque, P. (1994) Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunohistochemistry, Int. J. Cancer, 57, 822-829.
8. Kubben, H.J., Peeters-Haesenvoets, A., Engels, L.G., Baeten, C.G., Schutte, B., Arends, J.W., Stockbrugger, R.W. and Blijham, G.H. (1994) Proliferating cell nuclear antigen (PCNA): a new marker to study human colonie cell proliferation, Gut, 35, 530-535.
9. Pasricha, P.J., Bedi, A., O'Conner, K., Rashid, A., Akhtar, A.J., Zahurak, M.L., Piantadosi, S., Hamilton, S.R. and Giardiello, F.M. (1995) The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis, Gastroenterology, 109, 994-998.
10. Shivji, M.K.K., Kenny, M.K. and Wood, R.D. (1992) Proliferating cell nuclear antigen is required for DNA excision repair, Cell, 669, 3667-3674.
11. Celis, J.E. and Madsen, P. (1986) Increased nuclear cyclin/PCNA antigen staining of non-S-phase transformed human amnion cells engaged in nucleotide excision repair, FEBS Lett., 209, 277-283.
12. Toshi, L. and Bravo, R. (1988) Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis, J. Cell Biol., 107, 1623-1628.
13. Suzuki, H., Matsumoto, K. and Terabe, M. (1992) Ki-67 antibody labeling index in colorectal carcinoma, J. Clin. Gastroenterol., 15, 317-320.
14. Fairman, M.P. (1990) DNA polymerase delta/PCNA: actions and interactions, J. Cell Sci., 95, 1-4.
15. Bolton, W.E., Mikulka, W.R., Healy, C.G., Schimittling, R.J. and Kenyon, N.S. (1992) Expression of proliferation asso-ciated antigens in the cell cycle of synchronized mammalian cells, Cytometry, 13, 117-126.
16. Waddel, R.W., Gansar, G.F., Cerise, E.J. and Loughry, R.W. (1989) Sulindac for polyposis of the colon, Am. J. Surg., 157, 175-179.
17. Shiff, S.J., Qiao, L., Tsai, L.L. and Rigas, B. (1995) Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells, J. Clin. Invest., 96, 491-503.
18. Hanif, R., Pittas, A., Feng, Y., Koutsos, M., Qiao, L., Staiano-Coico, L., Shiff, S.J. and Rigas, B. (1996) Nonsteroidal anti-inflammatory drugs inhibit proliferation and induce apoptosis in colon cancer cells by a prostaglandin-independent pathway, Biochem. Pharmacol., 52, 237-245.
19. Overton, W.R. (1988) Modified histogram subtraction technique for analysis of flow cytometry data, Cytometry, 9, 619-626.
20. Qiao, L., Kozoni, V., Tsioulias, G.J., Koutsos, M.I., Hanif, R., Shiff, S.J. and Rigas, B. (1995) Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo, Biochim. Biophys. Acta, 1258, 215-223.
21. Nugent, K.P., Armenr, K.C., Spigelman, A.D., William, C.B. and Philips, R.K. (1993) Randomized controlled trial of the effect of sulindac sulfide on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis, Br. J. Surg., 80, 1618-1619.